Form 4: Castle Biosciences Director Kim Caple Reports Stock Transactions
SEC Form 4 Filing
Director Kim Caple of Castle Biosciences reports the vesting and subsequent disposal of restricted stock units on May 25, 2024.
Summary
- On May 25, 2024, Kim Caple, a director of Castle Biosciences, had 8,636 Restricted Stock Units (RSUs) vest.
- These RSUs, representing the right to receive one share of Castle Biosciences' common stock each, vested on the one-year anniversary of the grant date.
- Following the vesting, Caple disposed of 8,636 shares of common stock.
- After the reported transactions, Caple beneficially owns 13,341 shares of Castle Biosciences' common stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, helping investors understand their trading activities.
Key Dates
| Date | Description |
|---|---|
| 05/25/2024 | Date of transaction: vesting of Restricted Stock Units and disposal of shares. |
| 05/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.